Global Facial Injectables Market To Reach Worth USD 15.1 Bn By 2025

According to the latest report published by Brisk Insights “Facial Injectables Market – (Product Type –Botulinum Toxin, Hyaluronic Acid, Collagen, and Polymers and Particles (PPFs); Market Growth, Future Prospects and Competitive Analysis, 2017-2025” the market was valued at USD 5.1 Bn in 2015, and is expected to reach USD 15.1 Bn by 2025, expanding at a CAGR of 12.4% from 2017 to 2025.

Market Insights                                                  

Facial injectables or fillers are used in aesthetic medical procedures to enhance the facial look. Facial injectables are used with an intent to smoothen the wrinkles or scars on the face by filling or puffing up the target area. The major kinds of facial injectables used are botulinum toxin, hyaluronic acid, collagen, polymers and particles. The polymers and particles are further segmented into polymethylmethacrylate beads (PMMA microspheres), Poly-L-lactic acid, and calcium hydroxyapatite. Hyaluronic acid held the largest share in the global facial injectables market due to increased usage of this products as dermal fillers in aesthetic surgeries. Moreover, hyaluronic acid has major benefits as it increases hydration, improves elasticity and reverses free radical damage that protects from UV damage. These factors would continue to drive the market for hyaluronic acid with a healthy growth rate. Polymers and particles, are anticipated to be the fastest growing product segment by the end of the forecast period owing to having less side effects than other facial injectable products and higher longevity of the effect.

 Browse the full report Facial Injectables Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at https://www.briskinsights.com/report/facial-injectables-market

In base year 2015, North America was the most dominating regional market for facial injectables, with U.S. holding the largest market share in North America due to higher awareness about aesthetic surgical procedures in the region. Factors such organized regulatory framework and reimbursement scenarios are further assisting the facial injectables market in North America. According to International Society of Aesthetic Plastic Surgery (ISAPS), U.S. holds the largest number of facial filling procedures carried out all over the world. Asia-Pacific is anticipated as the most attractive market with highest growth rate during the forecast period. Rising disposable income, developing awareness regarding aesthetic and plastic surgeries in the regions, especially in the countries such as India, South Korea and China are driving the facial injectables market in Asia-Pacific. Moreover, rapidly developing healthcare infrastructure, medical tourism and booming entertainment industry would further boost the growth of facial injectables market in Asia-Pacific.

Market Competition Assessment:

The facial injectables market currently possesses limited number of companies having their products marketed. However, most of the companies are located in the North America and others developed regions. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America. The companies include, Merz Pharma GmbH & Co. KGaA, Bloomage BioTechnology Corporation Limited, Allergan, Inc., Galderma S.A., and Ipsen Group and Others.

Key Market Movements:

• Rise in aging population is the one of the driving factors for growing demand for plastic surgeries.
• Growing awareness and number of people opting for aesthetic surgeries is increasing the demand for facial injectables globally.
• Continuous introduction of new products and high level promotional activities through portals, magazines and other media are aggressively barraging information about such products.